Jacques Theurillat is a prominent figure in the field of longevity research, serving as a leader at ADC Therapeutics in West Switzerland. With a strong background in biomedicine, he focuses on innovative therapies aimed at extending healthy lifespan. His work involves collaboration with multidisciplinary teams to advance scientific understanding and practical applications in longevity. Jacques is dedicated to improving patient outcomes through cutting-edge research and development in the biotechnology sector.